STOCK TITAN

Zimmer Biomet Holdings, Inc. - $ZBH STOCK NEWS

Welcome to our dedicated page for Zimmer Biomet Holdings news (Ticker: $ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zimmer Biomet Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zimmer Biomet Holdings's position in the market.

Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) appoints Louis A. Shapiro, former President and CEO of Hospital for Special Surgery, to the Board, leveraging his extensive industry leadership experience and customer perspective.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
management
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
conferences
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) approves $0.24 per share cash dividend for Q4 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
dividends
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) to Present at 2023 Piper Sandler Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
conferences
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. reported a 5.0% increase in net sales for Q3 2023, reaching $1.754 billion, with diluted earnings per share of $0.77 and adjusted diluted earnings per share of $1.65. The company updated its 2023 reported revenue guidance due to currency expectations and reaffirmed 2023 constant currency revenue growth and adjusted earnings per share financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. announces Q3 earnings conference call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.36%
Tags
Rhea-AI Summary
Zimmer Biomet announces key updates to its Executive Leadership Team, including promotions and appointments. Wilfred van Zuilen promoted to Group President, EMEA; Mark Bezjak promoted to President of the Americas; Nitin Goyal appointed to the Executive Leadership Team. These changes reflect the company's focus on commercial execution and innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.13%
Tags
management
-
Rhea-AI Summary
Zimmer Biomet Holdings approves quarterly cash dividend of $0.24 per share for Q3 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Summary
Zimmer Biomet to present at Wells Fargo Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
conferences
Rhea-AI Summary
Zimmer Biomet appoints Ivan Tornos as President and CEO, reaffirms full-year 2023 financial guidance
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.82%
Tags
management
Zimmer Biomet Holdings, Inc.

NYSE:ZBH

ZBH Rankings

ZBH Stock Data

24.96B
204.56M
0.13%
90.96%
2.3%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
WARSAW

About ZBH

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.